A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses

Ting Qi, Yanming Chen, Honggui Li, Ya Pei, Shih Lung Woo, Xin Guo, Jiajia Zhao, Xiaoxian Qian, Joseph Awika, Yuqing Huo, Chaodong Wu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Metformin improves obesity-associated metabolic dysregulation, but has controversial effects on adipose tissue inflammation. The objective of the study is to examine the direct effect of metformin on adipocyte inflammatory responses and elucidate the underlying mechanisms. Adipocytes were differentiated from 3T3-L1 cells and treated with metformin at various doses and for different time periods. The treated cells were examined for the proinflammatory responses, as well as the phosphorylation states of AMPK and the expression of PFKFB3/iPFK2. In addition, PFKFB3/iPFK2-knockdown adipocytes were treated with metformin and examined for changes in the proinflammatory responses. The following results were obtained from the study. Treatment of adipocytes with metformin decreased the effects of lipopolysaccharide on inducing the phosphorylation states of JNK p46 and on increasing the mRNA levels of IL-1β and TNFα. In addition, treatment with metformin increased the expression of PFKFB3/iPFK2, but failed to significantly alter the phosphorylation states of AMPK. In PFKFB3/iPFK2-knockdown adipocytes, treatment with metformin did not suppress the proinflammatory responses as did it in control adipocytes. In conclusion, metformin has a direct effect on suppressing adipocyte proinflammatory responses in an AMPK-independent manner. Also, metformin increases adipocyte expression of PFKFB3/iPFK2, which is involved in the anti-inflammatory effect of metformin.

Original languageEnglish (US)
Pages (from-to)49-59
Number of pages11
JournalJournal of Molecular Endocrinology
Volume59
Issue number1
DOIs
StatePublished - Jul 1 2017

Fingerprint

Metformin
Adipocytes
AMP-Activated Protein Kinases
Phosphorylation
3T3-L1 Cells
Interleukin-1
Lipopolysaccharides
Adipose Tissue
Anti-Inflammatory Agents
Obesity
Inflammation
Messenger RNA

Keywords

  • Adipocyte
  • Inducible 6-phosphofructo-2-kinase
  • Inflammatory responses
  • Metformin
  • Obesity

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses. / Qi, Ting; Chen, Yanming; Li, Honggui; Pei, Ya; Woo, Shih Lung; Guo, Xin; Zhao, Jiajia; Qian, Xiaoxian; Awika, Joseph; Huo, Yuqing; Wu, Chaodong.

In: Journal of Molecular Endocrinology, Vol. 59, No. 1, 01.07.2017, p. 49-59.

Research output: Contribution to journalArticle

Qi, T, Chen, Y, Li, H, Pei, Y, Woo, SL, Guo, X, Zhao, J, Qian, X, Awika, J, Huo, Y & Wu, C 2017, 'A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses', Journal of Molecular Endocrinology, vol. 59, no. 1, pp. 49-59. https://doi.org/10.1530/JME-17-0066
Qi, Ting ; Chen, Yanming ; Li, Honggui ; Pei, Ya ; Woo, Shih Lung ; Guo, Xin ; Zhao, Jiajia ; Qian, Xiaoxian ; Awika, Joseph ; Huo, Yuqing ; Wu, Chaodong. / A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses. In: Journal of Molecular Endocrinology. 2017 ; Vol. 59, No. 1. pp. 49-59.
@article{8a3e1013e83e4719aa87c5d706f224f4,
title = "A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses",
abstract = "Metformin improves obesity-associated metabolic dysregulation, but has controversial effects on adipose tissue inflammation. The objective of the study is to examine the direct effect of metformin on adipocyte inflammatory responses and elucidate the underlying mechanisms. Adipocytes were differentiated from 3T3-L1 cells and treated with metformin at various doses and for different time periods. The treated cells were examined for the proinflammatory responses, as well as the phosphorylation states of AMPK and the expression of PFKFB3/iPFK2. In addition, PFKFB3/iPFK2-knockdown adipocytes were treated with metformin and examined for changes in the proinflammatory responses. The following results were obtained from the study. Treatment of adipocytes with metformin decreased the effects of lipopolysaccharide on inducing the phosphorylation states of JNK p46 and on increasing the mRNA levels of IL-1β and TNFα. In addition, treatment with metformin increased the expression of PFKFB3/iPFK2, but failed to significantly alter the phosphorylation states of AMPK. In PFKFB3/iPFK2-knockdown adipocytes, treatment with metformin did not suppress the proinflammatory responses as did it in control adipocytes. In conclusion, metformin has a direct effect on suppressing adipocyte proinflammatory responses in an AMPK-independent manner. Also, metformin increases adipocyte expression of PFKFB3/iPFK2, which is involved in the anti-inflammatory effect of metformin.",
keywords = "Adipocyte, Inducible 6-phosphofructo-2-kinase, Inflammatory responses, Metformin, Obesity",
author = "Ting Qi and Yanming Chen and Honggui Li and Ya Pei and Woo, {Shih Lung} and Xin Guo and Jiajia Zhao and Xiaoxian Qian and Joseph Awika and Yuqing Huo and Chaodong Wu",
year = "2017",
month = "7",
day = "1",
doi = "10.1530/JME-17-0066",
language = "English (US)",
volume = "59",
pages = "49--59",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",
publisher = "Society for Endocrinology",
number = "1",

}

TY - JOUR

T1 - A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses

AU - Qi, Ting

AU - Chen, Yanming

AU - Li, Honggui

AU - Pei, Ya

AU - Woo, Shih Lung

AU - Guo, Xin

AU - Zhao, Jiajia

AU - Qian, Xiaoxian

AU - Awika, Joseph

AU - Huo, Yuqing

AU - Wu, Chaodong

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Metformin improves obesity-associated metabolic dysregulation, but has controversial effects on adipose tissue inflammation. The objective of the study is to examine the direct effect of metformin on adipocyte inflammatory responses and elucidate the underlying mechanisms. Adipocytes were differentiated from 3T3-L1 cells and treated with metformin at various doses and for different time periods. The treated cells were examined for the proinflammatory responses, as well as the phosphorylation states of AMPK and the expression of PFKFB3/iPFK2. In addition, PFKFB3/iPFK2-knockdown adipocytes were treated with metformin and examined for changes in the proinflammatory responses. The following results were obtained from the study. Treatment of adipocytes with metformin decreased the effects of lipopolysaccharide on inducing the phosphorylation states of JNK p46 and on increasing the mRNA levels of IL-1β and TNFα. In addition, treatment with metformin increased the expression of PFKFB3/iPFK2, but failed to significantly alter the phosphorylation states of AMPK. In PFKFB3/iPFK2-knockdown adipocytes, treatment with metformin did not suppress the proinflammatory responses as did it in control adipocytes. In conclusion, metformin has a direct effect on suppressing adipocyte proinflammatory responses in an AMPK-independent manner. Also, metformin increases adipocyte expression of PFKFB3/iPFK2, which is involved in the anti-inflammatory effect of metformin.

AB - Metformin improves obesity-associated metabolic dysregulation, but has controversial effects on adipose tissue inflammation. The objective of the study is to examine the direct effect of metformin on adipocyte inflammatory responses and elucidate the underlying mechanisms. Adipocytes were differentiated from 3T3-L1 cells and treated with metformin at various doses and for different time periods. The treated cells were examined for the proinflammatory responses, as well as the phosphorylation states of AMPK and the expression of PFKFB3/iPFK2. In addition, PFKFB3/iPFK2-knockdown adipocytes were treated with metformin and examined for changes in the proinflammatory responses. The following results were obtained from the study. Treatment of adipocytes with metformin decreased the effects of lipopolysaccharide on inducing the phosphorylation states of JNK p46 and on increasing the mRNA levels of IL-1β and TNFα. In addition, treatment with metformin increased the expression of PFKFB3/iPFK2, but failed to significantly alter the phosphorylation states of AMPK. In PFKFB3/iPFK2-knockdown adipocytes, treatment with metformin did not suppress the proinflammatory responses as did it in control adipocytes. In conclusion, metformin has a direct effect on suppressing adipocyte proinflammatory responses in an AMPK-independent manner. Also, metformin increases adipocyte expression of PFKFB3/iPFK2, which is involved in the anti-inflammatory effect of metformin.

KW - Adipocyte

KW - Inducible 6-phosphofructo-2-kinase

KW - Inflammatory responses

KW - Metformin

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=85042164343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042164343&partnerID=8YFLogxK

U2 - 10.1530/JME-17-0066

DO - 10.1530/JME-17-0066

M3 - Article

VL - 59

SP - 49

EP - 59

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

IS - 1

ER -